| GTO ID | GTC2361 |
| Trial ID | NCT04406610 |
| Disease | Brain Glioma |
| Altered gene | GD2 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | GD2 CAR-T cells |
| Phase | Phase1|Phase2 |
| Recruitment status | Withdrawn |
| Title | CAR-T Cell Immunotherapy for GD2 Positive Glioma Patients |
| Year | 2020 |
| Country | China |
| Company sponsor | Fuda Cancer Hospital, Guangzhou |
| Other ID(s) | CAR-T |
| Cohort 1 | |||||||
|
|||||||